Real-life treatment persistence and treatment outcomes of Finnish patients with Inflammatory Bowel Disease receiving vedolizumab as first-line biological treatment

被引：0
|
作者：
Ylisaukko-Oja, T. [1 ]
Af Bjorkesten, C. G. [2 ,3 ]
Erbel, A. [2 ,3 ]
Nuutinen, H. [4 ]
Jussila, A. [5 ]
Molander, P. [2 ,3 ]
Koskela, R. [6 ]
Blomster, T. [6 ]
Pajala, M. [7 ]
Ilus, T. [5 ]
Haiko, P. [8 ]
Kovac, B. [8 ]
Silvola, S. [8 ]
Smith, S. [1 ]
Jokelainen, J. [1 ]
Sipponen, T. [2 ,3 ]
机构：
[1] MedEngine Oy, Med Data Sci, Helsinki, Finland
[2] Univ Helsinki, Abdominal Ctr Gastroenterol, Helsinki, Finland
[3] Helsinki Univ Hosp, Abdominal Ctr Gastroenterol, Helsinki, Finland
[4] Turku Univ Hosp, Div Gastroenterol, Dept Med, Turku, Finland
[5] Tampere Univ Hosp, Dept Gastroenterol & Alimentary Tract Surg, Tampere, Finland
[6] Oulu Univ Hosp, Dept Med, Div Gastroenterol, Oulu, Finland
[7] Kuopio Univ Hosp, Dept Internal Med, Kuopio, Finland
[8] Takeda Oy, Helsinki, Finland
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P629
引用
收藏
页码：758 / 759
页数：2
相关论文
共 50 条
  • [21] Influence of comorbidities on treatment considerations for first-line biologic prescribing in patients with inflammatory bowel disease in the UK
    Akbar, Ayesha
    Orchard, Tim
    Powell, Nick
    Selinger, Christian
    Tibbatts, Clare
    FRONTLINE GASTROENTEROLOGY, 2022, 13 (06) : 490 - 496
  • [22] Incidence of joint symptoms in patients with inflammatory bowel disease on treatment with vedolizumab
    Ruiz-Ramirez, M. A.
    Rodriguez-Merlos, P.
    Suarez, C.
    Plasencia-Rodriguez, C.
    Navarro-Compan, V.
    Poza, J.
    Martin-Arranz, E.
    Sanchez-Azofra, M.
    Rueda-Garcia, J. L.
    Garcia-Ramirez, L.
    Franco, K.
    Bonilla, G.
    Peiteado, D.
    Balsa, A.
    Martin-Arranz, M. D.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S473 - S473
  • [23] Vedolizumab in the induction and maintenance of inflammatory bowel disease treatment
    Tebar Marquez, D.
    REVISTA CLINICA ESPANOLA, 2014, 214 (03): : 161 - 162
  • [24] Efficacy of Vedolizumab as Induction Therapy for Inflammatory Bowel Disease in a 'real-life' Study
    Trefois, Quentin
    Descamps, Olivier
    Coche, Jean-Charles
    Schapira, Michael
    ACTA CLINICA BELGICA, 2016, 71 : 7 - 7
  • [25] Outcomes of Chemotherapy plus Cetuximab as First-line Treatment in Patients with Metastatic, Recurrent, Unresectable Head and Neck Cancers: Real-life Data
    Yazilitas, Dogan
    Sahinli, Hayriye
    Saylam, Guleser
    Imamoglu, Goksen Inanc
    Korkmaz, Mehmet Hakan
    Bayir, Omer
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (04): : 469 - 473
  • [26] First-line CyborD treatment for graft ineligible multiple myeloma patients: Real-life efficacy and tolerability.
    Duquette, Dominic
    Germain, Marie-Michelle
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Brian Bressler
    Jennifer Jones
    Tracy S. H. In
    Tommy Lan
    Cristian Iconaru
    John K. Marshall
    Advances in Therapy, 2023, 40 : 4421 - 4439
  • [28] Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease
    Bressler, Brian
    Jones, Jennifer
    In, Tracy S. H.
    Lan, Tommy
    Iconaru, Cristian
    Marshall, John K.
    ADVANCES IN THERAPY, 2023, 40 (10) : 4421 - 4439
  • [29] Real-world Effectiveness and Safety of Vedolizumab for the Treatment of Inflammatory Bowel Disease: The Scottish Vedolizumab Cohort
    Plevris, N.
    Chuah, C. S.
    Allen, R. M.
    Arnott, I. D.
    Brennan, P. N.
    Chaudhary, S.
    Churchhouse, A. M. D.
    Din, S.
    Donoghue, E.
    Gaya, D. R.
    Groome, M.
    Jafferbhoy, H. M.
    Jenkinson, P. W.
    Lam, W. L.
    Lyons, M.
    Macdonald, J. C.
    MacMaster, M.
    Mowat, C.
    Naismith, G. D.
    Potts, L. F.
    Saffouri, E.
    Seenan, J. P.
    Sengupta, A.
    Shasi, P.
    Sutherland, D. I.
    Todd, J. A.
    Veryan, J.
    Watson, A. J. M.
    Watts, D. A.
    Jones, G. R.
    Lees, C. W.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 (09): : 1111 - 1120
  • [30] First-line treatment of hymenoptera venom anaphylaxis: a 23-year real-life experience
    Gawlik, Radoslaw
    Marcak, Magdalena
    Kolodziej, Izabela
    Dzienniak, Anna
    Bozek, Andrzej
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 118 (03) : 375 - 377
12345